Harrow Inc (HROW) Live Share Price, Invest From India

Harrow Inc Stock Performance

as on December 11, 2025 at 2:29 am IST

Day's Low
Day's High
$48.12
Day's Price Range
$50.69
$50.21
4.16%
Downside
0.96%
Upside
52 Week's Low
52 Week's High
$20.85
52-Week Price Range
$50.72
$50.21
58.47%
Downside
1.02%
Upside

Harrow Inc share price movements today

Previous Close: $48.37
Open: $48.56
Volume: 534.2K
Day's Low - High: $48.12 - $50.69
52 Week Low - High: $20.85 - $50.72

Harrow Inc Historical Returns

1 Month Return: + 29.58 %
3 Month Return: + 27.25 %
1 Year Return: + 33.02 %
3 Year Return: + 360.55 %
5 Year Return: 0 %

Harrow Inc Stock Fundamentals & Key Indicators

Check Harrow Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

0.6167

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.64%

PE Ratio (TTM)

PEG Ratio

EBITDA

46.1M

Revenue (TTM)

250.0M

Profit Margin

-2.00%

Return On Equity TTM

-9.57%

Harrow Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Harrow Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Harrow Inc	BUY	$1.8B	NA	NA	-2.00%
United Therapeutics Corporation	BUY	$21.9B	NA	18.37	40.65%
Neurocrine Biosciences Inc.	BUY	$15.5B	72.52%	37.09	15.95%
Haleon Plc Spon Ads	BUY	$41.5B	NA	21.16	13.81%
Zoetis Inc.	BUY	$51.3B	-25.99%	19.49	28.21%

Stock Returns calculator for Harrow Inc Stock including INR - Dollar returns

The Harrow Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Harrow Inc investment value today

Current value as on today

₹1,38,983

Returns

₹38,983

(+38.98%)

Returns from Harrow Inc Stock

₹33,042 (+33.04%)

Dollar Returns*

₹5,941 (+5.94%)

Analyst Recommendation on Harrow Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Harrow Inc. Average target price of $70.62

Harrow Inc Share Price Target

Get share price movements and forecasts by analysts on Harrow Inc.

What analysts predicted

28.9%UPSIDE

Target Price

$70.62

Current Price

$50.21

Analyzed by

10 Analysts

Target

$70.62

Harrow Inc target price $70.62, a slight upside of 28.9% compared to current price of $50.21. According to 10 analysts rating.

Harrow Inc Stock’s Investor Sentiment and Interest

Search interest for Harrow Inc Stock has increased by 167% in the last 30 days, reflecting an upward trend in search activity.

Time period: November 11, 2025 to December 11, 2025

Change:167% versus previous 30 day period

Harrow Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	33	34	36	34	48	49	66	47	63	71
Gross Profit	23	24	25	24	36	37	52	32	47	53
Operating Income	2	1	-4	-6	1	1	12	-11	11	14
EBITDA	5	4	-1	-4	4	4	17	-6	15	11
Interest Expense	5	5	5	5	5	5	6	6	6	6
Depreciation	3	3	3	3	3	3	4	4	4	4
Income Before Tax	-4	-2	-9	-13	-5	-4	6	-17	4	1
Income Tax Expense	0	1	0	3	0	0	0	-	-	-
Net Income	-4	-4	-9	-13	-6	-4	6	-17	4	1
Net Profit Margin	-12.64%	-12.81%	-25.16%	-39.22%	-13.23%	-8.57%	10.14%	-37.17%	7.84%	1.42%

Harrow Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	9	19	26	41	51	48	72	88	130	199
Gross Profit	4	10	13	24	34	34	54	63	90	150
Operating Income	-14	-15	-12	-5	-4	0	1	1	0	8
EBITDA	-14	-14	-10	-3	1	2	5	4	11	22
Interest Expense	1	2	3	2	2	2	5	7	21	22
Depreciation	-	-	1	1	2	2	2	3	12	14
Income Before Tax	-15	-19	-12	14	0	-3	-17	-14	-23	-17
Income Tax Expense	1	0	0	-19	0	0	0	0	0	0
Net Income	-15	-19	-11	14	0	-3	-18	-14	-24	-17
Net Profit Margin	-163.64%	-95.71%	-44.76%	35.35%	0.33%	-6.87%	-24.85%	-15.90%	-18.75%	-8.76%

Harrow Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-4	-9	-13	-6	-4	6	-17	4	1
Operating Cash Flow	-1	8	-4	-2	2	-17	19	0	16
Investing Cash Flow	-20	0	0	5	0	-37	0	0	0
Financing Cash Flow	64	0	0	0	0	29	0	-12	4
Change in Cash	42	8	-5	2	1	-25	19	-13	21

Harrow Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-19	-11	14	0	-3	-18	-14	-24	-17
Operating Cash Flow	-11	-8	0	0	-1	5	1	3	-22
Investing Cash Flow	-7	0	-2	-1	0	-18	-1	-152	-33
Financing Cash Flow	24	4	4	-1	1	51	54	126	28
Change in Cash	6	-4	2	-1	0	37	54	-22	-26

Global Institutional Holdings in Harrow Inc

Funds	Holdings
Opaleye Management Inc	10.55%
BlackRock Inc	6.93%
Private Capital Management, LLC	5.26%
Vanguard Group Inc	5.05%
BRAIDWELL LP	2.36%

See all

Insights on Harrow Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, HROW stock has moved up by 29.6%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 47.83M → 71.63M (in $), with an average increase of 18.0% per quarter
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, HROW has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 33.9% return, outperforming this stock by 0.9%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 4.99M → 1.02M (in $), with an average decrease of 79.6% per quarter

About Harrow Inc

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. its products portfolio includes topical eye drop drug candidates, including surf-100 and surf-200; surf-300, an oral capsule for treating patients suffering from ocular surface diseases, and ded signs and symptoms; klarity drops to protect and rehabilitate the ocular surface pathology for patients with ded; melt-100, a drug that is administered sublingually for conscious sedation during cataract surgery; may-66 that is used for the treatment of symptoms associated with peyronie's diseas

Organisation	Harrow Inc
Headquarters	1A Burton Hills Boulevard, Nashville, TN, United States, 37215
Industry	Health Technology
CEO	Mr. Mark L. Baum J.D.
E-voting on shares	Click here to vote

Key Management of Harrow Inc

Name	Title
Mr. Mark L. Baum J.D.	CEO & Chairman of the Board
Mr. Andrew R. Boll C.F.A., C.M.A.	President, CFO & Corporate Secretary
Dr. Amir W. Shojaei Ph.D., Pharm.D.	Chief Scientific Officer
Ms. Kim Barratt	Chief Talent Officer
Mr. Greg DiPasquale	Senior VP & Head of Commercial
Dr. Prashanth S. Annavajjhala	Chief of Staff
Mr. Randall E. Pollard	Chief Accounting Officer
Mr. Michael D. Biega	Vice President of Investor Relations & Communications
Mr. Brett A. Burrell	Vice President of Legal & Compliance
Dr. Mark A. Mannebach Ph.D., R.Ph.	Head of Regulatory Affairs & Pharmacovigilance

FAQs

What is Harrow Inc share price today?

Harrow Inc share price today is $50.21 as on December 11, 2025 at 2:29 am IST at the close of the market. Harrow Inc share today touched a day high of $50.69 and a low of $48.12.

What is the 52 week high and 52 week low for Harrow Inc share?

Harrow Inc share touched a 52 week high of $50.72 on September 26, 2025 and a 52 week low of $20.85 on April 9, 2025. Harrow Inc stock price today i.e. December 11, 2025 at 2:29 am IST is closed at $50.21,which is 1.01% down from its 52 week high and 140.82% up from its 52 week low.

What is Harrow Inc's market capitalisation today?

Harrow Inc market capitalisation is $0.00T as on December 11, 2025 at 2:29 am IST.

How to invest in Harrow Inc Stock (HROW) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Harrow Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Harrow Inc Shares that will get you 0.0299 shares as per Harrow Inc share price of $50.21 per share as on December 11, 2025 at 2:29 am IST.

What is the minimum amount required to buy Harrow Inc Stock (HROW) from India?

Indian investors can start investing in Harrow Inc (HROW) shares with as little as ₹89.928 or $1 (as of December 11, 2025 at 2:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹899.28 in Harrow Inc stock (as per the Rupee-Dollar exchange rate as on December 11, 2025 at 2:38 pm IST). Based on Harrow Inc share’s latest price of $50.21 as on December 11, 2025 at 2:29 am IST, you will get 0.1992 shares of Harrow Inc. Learn more about fractional shares .